The hostile bid from Roche to take over Illumina spills over to more names (previous: PACB, GNOM, LIFE) on M&A speculation - as Sequenom (SQNM +2.2%), Qiagen (QGEN +1.5%), and Luminex (LMNX +1.1%) all catch bids in early trading.
The hostile bid from Roche to take over Illumina spills over to more names (previous: PACB,...
From other sites
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
at CNBC.com (Mar 15, 2013)
at CNBC.com (Apr 25, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs